Modeling Brain Pathology of Niemann-Pick Disease Type C Using Patient-Derived Neurons

Lena F. Burbulla, Jessica M. Mc Donald, Clarissa Valdez, Fanding Gao, Eileen H. Bigio, Dimitri Krainc*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Background: Niemann-Pick disease type C (NPC) is a rare autosomal-recessive lysosomal storage disease that is also associated with progressive neurodegeneration. NPC shares many pathological features with Alzheimer's disease, including neurofibrillary tangles, axonal spheroids, β-amyloid deposition, and dystrophic neurites. Here, we examined if these pathological features could be detected in induced pluripotent stem cell (iPSC)-derived neurons from NPC patients. Methods: Brain tissues from 8 NPC patients and 5 controls were analyzed for histopathological and biochemical markers of pathology. To model disease in culture, iPSCs from NPC patients and controls were differentiated into cortical neurons. Results: We found hyperphosphorylated tau, altered processing of amyloid precursor protein, and increased Aβ42 in NPC postmortem brains and in iPSC-derived cortical neurons from NPC patients. Conclusion: Our findings demonstrated that the main pathogenic phenotypes typically found in NPC brains were also observed in patient-derived neurons, providing a useful model for further mechanistic and therapeutic studies of NPC.

Original languageEnglish (US)
Pages (from-to)1022-1027
Number of pages6
JournalMovement Disorders
Volume36
Issue number4
DOIs
StatePublished - Apr 2021

Funding

We are grateful to Niccolo E. Mencacci for helpful comments, Callen L. Spencer for staining of brain tissue sections, Northwestern Stem Cell Core Facility for generation of iPSC lines, NICHD Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore for brain tissues. This work was supported by NINDS grants R01 NS076054 and R37 NS096241 (to D.K.), NIA grant AG 13854 (to E.H.B.), and in part by Lysosomal Therapeutics, Inc. (to J.M.M.). This work was supported by NINDS grants R01 NS076054 and R37 NS096241 (to D.K.), NIA grant AG 13854 (to E.H.B.), and in part by Lysosomal Therapeutics, Inc. (to J.M.M.). Funding agencies: We are grateful to Niccolo E. Mencacci for helpful comments, Callen L. Spencer for staining of brain tissue sections, Northwestern Stem Cell Core Facility for generation of iPSC lines, NICHD Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore for brain tissues. This work was supported by NINDS grants R01 NS076054 and R37 NS096241 (to D.K.), NIA grant AG 13854 (to E.H.B.), and in part by Lysosomal Therapeutics, Inc. (to J.M.M.).

Keywords

  • Niemann-Pick disease; iPSC; disease modeling; brain pathology

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Fingerprint

Dive into the research topics of 'Modeling Brain Pathology of Niemann-Pick Disease Type C Using Patient-Derived Neurons'. Together they form a unique fingerprint.

Cite this